Verrica Pharmaceuticals Reports Third Quarter 2023 Financial Results

<p>– Strong awareness and interest in prescribing YCANTH™ among dermatologists and pediatricians – – Over 112 million lives covered to date on commercial insurance and managed Medicaid plans – – Conference Call Scheduled for Today at 8:30 am ET – WEST CHESTER, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) &#8212; Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a [&#8230;]</p>
<p>The post <a href="https://forextv.com/top-news/verrica-pharmaceuticals-reports-third-quarter-2023-financial-results/">Verrica Pharmaceuticals Reports Third Quarter 2023 Financial Results</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>